Product NDC: | 52544-733 |
Proprietary Name: | Dilacor |
Non Proprietary Name: | diltiazem hydrochloride |
Active Ingredient(s): | 180 mg/1 & nbsp; diltiazem hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52544-733 |
Labeler Name: | Watson Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020092 |
Marketing Category: | NDA |
Start Marketing Date: | 19920529 |
Package NDC: | 52544-733-01 |
Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52544-733-01) |
NDC Code | 52544-733-01 |
Proprietary Name | Dilacor |
Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52544-733-01) |
Product NDC | 52544-733 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | diltiazem hydrochloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19920529 |
Marketing Category Name | NDA |
Labeler Name | Watson Pharma, Inc. |
Substance Name | DILTIAZEM HYDROCHLORIDE |
Strength Number | 180 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |